Wiki Parkinson

Parkinson’s Disease Statistics in the U.S.

Parkinson’s disease (PD) is a long-term neurological disorder that affects movement and can significantly affect quality of life. Being aware of its prevalence, incidence, and mortality in the United States is valuable for awareness, research, and health planning.

Prevalence and Incidence:

Annual Diagnoses: More recent studies have indicated that approximately 90,000 individuals are diagnosed with Parkinson’s disease each year in the U.S., a 50% increase from previous estimates of 60,000 annual diagnoses.
Parkinson’s Foundation
+1
Parkinson’s Foundation
+1

Total Cases: In 2020, close to one million individuals in the U.S. had Parkinson’s disease. This is expected to increase to 1.2 million by 2030. ​
Parkinson’s Foundation
+1
anidasopd.org
+1

Mortality Rates:

Age-Adjusted Death Rates: During 1999-2017, age-adjusted death rates for Parkinson’s disease among adults aged 65 and older increased from 41.7 to 65.3 per 100,000 population. Specifically, men’s rates increased from 65.2 to 97.9 per 100,000, while women’s rates increased from 28.4 to 43.0 per 100,000 over these years. ​CDC

State Differences: Parkinson’s disease mortality rates vary by state. For specific, state-level mortality data, see the Centers for Disease Control and Prevention (CDC) resources. ​
CDC

Demographic Insights:

Age Factor: The risk of Parkinson’s disease increases with advancing age, particularly in individuals aged 65 years and older. Age remains the primary risk factor for the development of PD.
Parkinson’s Foundation

Gender Variations: Males have a greater risk of developing Parkinson’s disease than females in all age groups. ​
Parkinson’s Foundation

Global Perspective:

Worldwide Prevalence: Around 7 to 10 million individuals worldwide suffer from Parkinson’s disease. Prevalence rates are 41 per 100,000 for individuals in their 40s and over 1,900 per 100,000 for individuals older than 80 years. ​
Parkinson’s News Today

Conclusion:

The increasing prevalence and incidence of Parkinson’s disease in the United States highlight the need for continued studies, enhanced healthcare services, and treatment resources for affected individuals and their family members. With population ageing, dealing with the challenges posed by this neurodegenerative disorder becomes increasingly significant day by day.
Parkinson’s disease (PD) is an prevalent neurodegenerative disorder in Europe of significant public health concern.

Prevalence in Europe:

Over 1.2 million Europeans have Parkinson’s disease, which is one of the most common neurodegenerative diseases in Europe.
Wiki Parkinson

Age and Sex Distribution:

PD predominantly affects older people, and the prevalence increases with age. Notably, 10% of patients are under the age of 50.
Parkinson’s Europe

There are slightly more men than women affected, with an age-standardized prevalence ratio of 1.4:1.
The Lancet

Projected Trends:

Parkinson’s is the fastest-growing neurological condition globally. It has been estimated that the prevalence of Parkinson’s will double to 20 million by 2050.

Parkinson’s Europe
+1
thesun.co.uk
+1

These statistics point out the growing prevalence of Parkinson’s disease in Europe, underlining the importance of better healthcare policies, studies, and support mechanisms to address this emerging public health concern.

The Parkinson’s Protocol™ By Jodi Knapp Parkinson’s disease cannot be eliminated completely but its symptoms can be reduced, damages can be repaired and its progression can be delayed considerably by using various simple and natural things. In this eBook, a natural program to treat Parkinson’s disease is provided online. it includes 12 easy steps to repair your body and reduce the symptoms of this disease.